Glenmark Pharmaceuticals is increasing focus on research-driven products and international expansion to strengthen its long-term growth strategy. The company continues expanding in respiratory, dermatology, and specialty medicine segments.
Global demand for affordable healthcare solutions and generic medicines remains supportive for Indian pharmaceutical exporters. Glenmark is also focusing on regulatory approvals and innovation-based product development.
Analysts believe the company could benefit from rising healthcare spending and improving export opportunities across international markets.
